ArticleInflammatory bowel diseases2025

Novel Transcriptomic Signatures in Fibrostenotic Crohn's Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets.

Animesh Acharjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.